Clicky

Black Diamond Therapeutics, Inc.(BDTX) News

Date Title
Jun 26 Veru And Two Other Penny Stocks To Consider
Mar 20 Servier and Black Diamond sign deal for solid tumours therapy
Mar 19 Top Midday Gainers
Mar 19 Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy
Feb 19 NAYA Biosciences Announces Nomination of New Board Members
Feb 17 February 2025 US Penny Stocks With Promising Prospects
Dec 12 US Penny Stocks Spotlight: Information Services Group Among 3 Top Picks
Sep 23 Black Diamond Therapeutics' Lead Drug Candidate Shows Initial Anti-tumor Activity In Certain Type Of Lung Cancer Resistant To AstraZeneca's Drug
May 29 Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
May 22 Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) is favoured by institutional owners who hold 60% of the company
May 10 Should You Buy Black Diamond Therapeutics (BDTX) Ahead of Earnings?
May 9 Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Apr 24 Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 15 Black Diamond (BDTX) Upgraded to Buy: What Does It Mean for the Stock?
Apr 11 Black Diamond Therapeutics Announces Changes to Board of Directors
Apr 8 Wall Street Analysts Predict a 129.25% Upside in Black Diamond (BDTX): Here's What You Should Know
Apr 7 Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting
Apr 3 Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
Mar 22 How Much Upside is Left in Black Diamond Therapeutics (BDTX)? Wall Street Analysts Think 95.93%
Mar 14 Black Diamond Therapeutics Inc (BDTX) Reports Q4 and Full Year 2023 Financials, Advances ...